News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Bexion Pharmaceuticals Receives Outstanding Biotech Innovation Award


4/19/2011 7:54:59 AM

COVINGTON, Ky., April 18, 2011 /PRNewswire/ -- Bexion Pharmaceuticals was named the Biotech Innovation Award winner at the Cincinnati USA Innovation Awards program sponsored by the Cincinnati Business Courier, the Cincinnati USA Regional Chamber and CincyTech. The Innovation Awards celebrate outstanding innovation and the companies and people who have shown how new ideas can be developed into fuel for the regional Tri-State (Ohio/Kentucky/Indiana) economic engine.

"The Bexion team is honored to be the very first winner of the Biotech Innovation Award," stated Dr. Ray Takigiku, co-founder and CEO of Bexion. "Cancer treatment and diagnosis is in dire need of innovation. We believe, and the award judges appear to agree, that our approach represents an entirely new, exciting and potentially paradigm-shifting approach to the treatment of cancer."

Bexion is developing BXQ-350 nanovesicles as a potential treatment for the form of brain cancer called glioblastoma. BXQ-350 nanovesicles have an affinity for the membrane patches that are common in many types of tumor cells including glioblastoma cells. Bexion's studies have shown effectiveness in the laboratory in multiple animal tumor models, and across a remarkable range of tumors in the test tube.

About Bexion Pharmaceuticals:

Bexion Pharmaceuticals is focused on the development and commercialization of innovative cures for cancer. Initial products are based on a patent-protected and proprietary platform technology licensed from Cincinnati Children's Hospital Medical Center. The technology has demonstrated potential for development as therapeutics, diagnostics and surgical imaging reagents, as well as carriers for other pharmaceutical agents, such as oligonucleotides. For more information, visit www.bexionpharma.com.


For media enquiries contact:

For investor enquiries contact:

Margaret van Gilse

Chuck Scheper

VP, Business Development

Chair

Bexion Pharmaceuticals, LLC

Bexion Pharmaceuticals, LLC

632 Russell Street

632 Russell Street

Covington, KY 41011

Covington, KY 41011

Phone: (513) 833-7065

Phone: (513)252-2169

mvangilse@bexionpharma.com

cscheper@bexionpharma.com




SOURCE Bexion Pharmaceuticals


Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES